It's a long way to the top! Congenital venous anomalies and left isomerism limiting atrial fibrillation transcatheter ablation

Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and it is associated with a high burden of mortality and morbidity worldwide. Catheter ablation is increasingly used to improve symptoms and prognosis in selected patients. Lower limb venous access with subsequent transsep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current problems in cardiology 2024-05, Vol.49 (5), p.102467-102467, Article 102467
Hauptverfasser: De Innocentiis, Carlo, Buonpane, Angela, Totaro, Antonio, Restaino, Gennaro, Astore, Pasquale, Guarino, Martina, Langella, Valerio, Gallina, Sabina, Santamaria, Matteo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and it is associated with a high burden of mortality and morbidity worldwide. Catheter ablation is increasingly used to improve symptoms and prognosis in selected patients. Lower limb venous access with subsequent transseptal approach to the left atrium is the standard procedure for atrial fibrillation catheter ablation. We report an unusual case of complex venous anomaly with a left-sided inferior vena cava with hemiazygos continuation to a persistent left superior vena cava draining in an enlarged coronary sinus in a patient with persistent atrial fibrillation scheduled for transcatheter ablation. Lower limb venous anomalies may limit a standard transseptal approach to the left atrium thus precluding an effective catheter ablation procedure for atrial fibrillation. Alternative interventions, such as unconventional percutaneous access, thoracoscopic approach and “ablate and pace” procedures, may be necessary in patients with symptomatic atrial fibrillation and complex venous anomalies.
ISSN:0146-2806
1535-6280
DOI:10.1016/j.cpcardiol.2024.102467